S226A_XENLA
ID S226A_XENLA Reviewed; 558 AA.
AC Q66J54;
DT 18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT 11-OCT-2004, sequence version 1.
DT 03-AUG-2022, entry version 82.
DE RecName: Full=Solute carrier family 22 member 6-A;
DE AltName: Full=Organic cation transporter 1-A;
DE AltName: Full=Renal organic anion transporter 1-A;
DE Short=ROAT1-A;
GN Name=slc22a6-a; Synonyms=oat1-a;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Kidney;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Involved in the renal elimination of endogenous and exogenous
CC organic anions. Mediates the sodium-independent uptake of p-
CC aminohippurate (PAH), 2,3-dimercapto-1-propanesulfonic acid (DMPS),
CC cidofovir, adefovir, 9-(2-phosphonylmethoxyethyl) guanine (PMEG), 9-(2-
CC phosphonylmethoxyethyl) diaminopurine (PMEDAP), ochratoxin (OTA),
CC acyclovir (ACV), 3'-azido-3-'deoxythymidine (AZT), cimetidine (CMD),
CC 2,4-dichloro-phenoxyacetate (2,4-D), hippurate (HA), indoleacetate
CC (IA), indoxyl sulfate (IS) and 3-carboxy-4-methyl-5-propyl-2-
CC furanpropionate (CMPF) and edaravone sulfate. PAH uptake is inhibited
CC by p-chloromercuribenzenesulphonate (PCMBS), diethyl pyrocarbonate
CC (DEPC), indomethacin, sulindac, diclofenac, carprofen, okadaic acid,
CC benzothiazolylcysteine (BTC), S-chlorotrifluoroethylcysteine (CTFC),
CC cysteine S-conjugates S-dichlorovinylcysteine (DCVC), furosemide,
CC steviol, phorbol 12-myristate 13-acetate (PMA), calcium ionophore
CC A23187, benzylpenicillin, bumetamide, losartan, probenecid, phenol red,
CC urate, glutarate and alpha-ketoglutarate (By similarity).
CC {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC protein {ECO:0000305}.
CC -!- DOMAIN: Multiple cysteine residues are necessary for proper targeting
CC to the plasma membrane. {ECO:0000250}.
CC -!- PTM: Glycosylated. Glycosylation is necessary for proper targeting of
CC the transporter to the plasma membrane (By similarity). {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC081055; AAH81055.1; -; mRNA.
DR RefSeq; NP_001087661.1; NM_001094192.1.
DR AlphaFoldDB; Q66J54; -.
DR SMR; Q66J54; -.
DR DNASU; 447485; -.
DR GeneID; 447485; -.
DR KEGG; xla:447485; -.
DR CTD; 447485; -.
DR Xenbase; XB-GENE-22061136; slc22a8.S.
DR OrthoDB; 704438at2759; -.
DR Proteomes; UP000186698; Chromosome 4S.
DR Bgee; 447485; Expressed in kidney and 2 other tissues.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0015075; F:ion transmembrane transporter activity; IEA:UniProt.
DR Gene3D; 1.20.1250.20; -; 1.
DR InterPro; IPR020846; MFS_dom.
DR InterPro; IPR005828; MFS_sugar_transport-like.
DR InterPro; IPR036259; MFS_trans_sf.
DR InterPro; IPR004749; Orgcat_transp/SVOP.
DR InterPro; IPR005829; Sugar_transporter_CS.
DR Pfam; PF00083; Sugar_tr; 1.
DR SUPFAM; SSF103473; SSF103473; 1.
DR TIGRFAMs; TIGR00898; 2A0119; 1.
DR PROSITE; PS50850; MFS; 1.
PE 2: Evidence at transcript level;
KW Cell membrane; Membrane; Reference proteome; Transmembrane;
KW Transmembrane helix.
FT CHAIN 1..558
FT /note="Solute carrier family 22 member 6-A"
FT /id="PRO_0000324175"
FT TOPO_DOM 1..15
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 16..36
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 37..140
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 141..161
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 162..167
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 168..188
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 189..197
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 198..218
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 219..225
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 226..246
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 247..253
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 254..274
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 275..342
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 343..363
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 364..369
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 370..390
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 391..400
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 401..421
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 422..428
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 429..449
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 450..462
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT TRANSMEM 463..483
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 484..488
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 489..509
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 510..558
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT REGION 539..558
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 558 AA; 62453 MW; 7A56F314DAB130A4 CRC64;
MSFAELLERT GGMGRFQITQ VALMCFPILL MASHNLLQNF SAAIPDHKCK ANDTWYQSNN
TDRMGYVRLS APLDADGQPD RCLEYVEVQW MIAGTNRTWA NSSQLATRPC TEGWEYSKDE
FNSTIITEWD LVCGHKNRRQ LAQSVYMGGV LVGAIILGGL SDRYGRRALL IWSYFQMAVS
GLCSAFSPNY LSYCIFRFLT GMALSGIGLN TTALIVEWVP TRVRTITGTL AGFSYTVGQL
LLAGLAYAMR DWRWLQLCVS LPFFIFFLYS WWFPESARWL VLSGKTERAV KEMKKVAKLN
GKEEEGEKIT LESMRSDMIK ELACAKSSYT VIDLIRTSTI RRISCALSLV WFSTSFAYYG
LAMDLQNFNV SIYLIQVIFG AVDFPAKIFS TTAMIYVGRK FTQLMSLILG GVVILANSFV
PHEMQTVRTG MAVFGKGCLA ASFSCVFLYT TELYPTVIRQ SGLGLCSTMA RIGGIVAPLV
KILGEYYPFL PLVIYGGAPI ISGLCVFFLP ETVNKPLPDT IEEVEKRIKA PKKENEMNEI
VSLKKKEGMK ENPVNDVL